ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 161 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $1,143,000 | +28.4% | 27,300 | 0.0% | 0.12% | +30.7% |
| Q1 2015 | $890,000 | -97.3% | 27,300 | -97.3% | 0.09% | -97.5% |
| Q4 2014 | $32,617,000 | -75.1% | 1,027,300 | -80.5% | 3.50% | -77.3% |
| Q3 2014 | $130,733,000 | +10.2% | 5,280,000 | +0.6% | 15.45% | +28.9% |
| Q2 2014 | $118,598,000 | -11.4% | 5,250,000 | -4.5% | 11.99% | +24.9% |
| Q1 2014 | $133,816,000 | -16.6% | 5,500,000 | -14.3% | 9.60% | -48.7% |
| Q4 2013 | $160,434,000 | -19.8% | 6,419,898 | -11.9% | 18.69% | -10.5% |
| Q3 2013 | $200,133,000 | -4.4% | 7,285,510 | -36.8% | 20.89% | -24.7% |
| Q2 2013 | $209,266,000 | – | 11,529,810 | – | 27.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |